West Virginia Code of State Rules › Agency 19 - Registered Nurses, WV Board of › Title 19 - PROCEDURAL RULES WEST VIRGINIA BOARD OF EXAMINERS FOR REGISTERED PROFESSIONAL NURSES › Series 19-14 - Practitioner Requirements for Accessing the West Virginia Controlled Substances Monitoring Program Database › Section 19-14-2 - Definitions

Current through Register Vol. XLI, No. 28, July 12, 2024
2.1. As used in
				this rule, the following words and terms have the following meaning:
2.1.a. "Administering" means the direct
				application of a drug to the body of a patient by injection, inhalation,
				ingestion or any other means by a registered professional nurse with valid
				prescribing privileges.
2.1.b.
				"Authorized agent" means an individual, who is an employee of any of the
				covered persons or entities permitted to have access to the central repository
				who is specifically designated by the Advanced Practice Registered Nurse with
				prescriptive privileges to access the central repository on behalf of the
				covered person or entity.
2.1.c.
				"Board" means the West Virginia Board for Registered Nurses as described at W.
				Va. Code §
										30-7-1 et seq.
2.1.d. "Chronic nonmalignant pain" means pain
				that has persisted after reasonable medical efforts have been made to relieve
				the pain or cure its cause and that has continued, either continuously or
				episodically, for longer than 3 continuous months. For purposes of this rule,
				"chronic nonmalignant pain" does not include pain associated with a terminal
				condition or illness or with a progressive disease that, in the normal course
				of progression, may reasonably be expected to result in a terminal condition or
				illness.
2.1.e. "Controlled
				substance" means a drug that is classified by federal or state law in Schedules
				I, II, Ill, IV or V, as defined in W. Va. Code §
										60A-2-204 through 212.
2.1.f. "Course of treatment" means the period
				of time necessary to effect a cure for an acute disease, or the period of time
				from one office visit until the next scheduled or anticipated office visit for
				a chronic disease.
2.1.g. "CSMP"
				means the West Virginia Controlled Substances Monitoring Program repository and
				database.
2.1.h. "DEA registration
				identification number" means the federal Drug Enforcement Administration
				registration identification number issued to a practitioner.
2.1.i. "Dispensing" means the preparation and
				delivery of a drug to an ultimate user by or pursuant to a lawful order of a
				practitioner, including the prescribing, packaging, labeling, administering or
				compounding necessary to prepare the drug for that delivery.
2.1.j. "Medical records" means records
				including the medical history and physical examination; diagnostic, therapeutic
				and laboratory results; evaluations and consultations; treatment objectives;
				discussion of risks and benefits; informed consent; treatments; medications
				(including date, type, dosage and quantity provided); instructions and
				agreements; and periodic reviews.
2.1.k. "Opioid" means natural and
				semi-synthetic derivatives of the opium poppy, as well as similar synthetic
				compounds that have analgesic or pain
-
relieving
				properties because of their effects in the central nervous system. These
				include, but are not limited to, codeine, morphine, hydromorphone, hydrocodone,
				oxycodone, methadone, and fentanyl.
2.1.l. "Pain-relieving controlled substance"
				means, but is not limited to, an opioid or other drug classified as a Schedule
				II through V controlled substance and recognized as effective for pain relief
				and excludes any drug that has no accepted medical use in the United States or
				lacks accepted safety for use in treatment under medical supervision including,
				but not limited to, any drug classified as a Schedule I controlled
				substance.
2.1.m. "Patient" means a
				person presenting himself or herself for treatment who is not considered by the
				practitioner as suffering from a terminal illness.
2.1.n. "Practitioner" means a registered
				professional nurse licensed pursuant to the provisions of The Nurse Practice
				Act W. Va. Code §
										30-7-1 et seq. who possesses a
				valid DEA registration identification.
2.1.o. "Provision" means prescribing or
				administering.
2.1.p. "Terminal
				illness" means an incurable or irreversible condition as diagnosed by the
				attending physician or a qualified physician for which the administration of
				life-prolonging intervention will serve only to prolong the dying
				process.